{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:9002"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:9002","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Characterising the phenotype and impact of adipose in idiopathic intracranial hypertension","abstract":"Idiopathic intracranial hypertension (IIH) is a rare disease that primarily affects obese women of reproductive age, characterised by raised intracranial pressure (ICP) and papilloedema that drives chronic debilitating headache and visual loss. The aetiology of IIH is uncertain, however it is clear that weight loss is therapeutic and reduces ICP, headache, and visual morbidity. Novel data has highlighted that female IIH patients have an androgen excess phenotype. However the role of adipose tissue and androgens in the pathogenesis of IIH remains unclear. Utilising RNA-sequencing, NMR-based metabolomics and secretomic techniques, it has been identified that ex vivo subcutaneous adipose tissue from female IIH patients has features of glucocorticoid excess including increased lipolysis, ribosomal subunit depletion and a preference for lipid synthesis, driven by intra-adipose cortisol accumulation. Moreover, this phenotype is driving hyperleptinaemia in IIH patients. Additionally, a novel in vitro Na+/K+ ATPase activity assay was developed, which demonstrated that testosterone increases Na+/K+ ATPase activity, suggesting capacity to increase ICP. Together, these data highlight that adipose tissue in IIH has characteristics of glucocorticoid excess, contributing to a specific metabolic phenotype and that testosterone could be driving raised intracranial pressure, highlighting routes for the development of novel therapeutics and treatments for IIH.","abstract_html":"Idiopathic intracranial hypertension (IIH) is a rare disease that primarily affects obese women of reproductive age, characterised by raised intracranial pressure (ICP) and papilloedema that drives chronic debilitating headache and visual loss. The aetiology of IIH is uncertain, however it is clear that weight loss is therapeutic and reduces ICP, headache, and visual morbidity. Novel data has highlighted that female IIH patients have an androgen excess phenotype. However the role of adipose tissue and androgens in the pathogenesis of IIH remains unclear. Utilising RNA-sequencing, NMR-based metabolomics and secretomic techniques, it has been identified that ex vivo subcutaneous adipose tissue from female IIH patients has features of glucocorticoid excess including increased lipolysis, ribosomal subunit depletion and a preference for lipid synthesis, driven by intra-adipose cortisol accumulation. Moreover, this phenotype is driving hyperleptinaemia in IIH patients. Additionally, a novel in vitro Na+/K+ ATPase activity assay was developed, which demonstrated that testosterone increases Na+/K+ ATPase activity, suggesting capacity to increase ICP. Together, these data highlight that adipose tissue in IIH has characteristics of glucocorticoid excess, contributing to a specific metabolic phenotype and that testosterone could be driving raised intracranial pressure, highlighting routes for the development of novel therapeutics and treatments for IIH.","abstract_has_math":false,"creators":["Westgate, Connar Stanley James"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-07","date_published":"2019-07","updated_at":"2026-11-19T09:30:27Z","subjects":["QH301 Biology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/9002/7/Westgate2019PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A9002","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["mrc","other"]},{"key":"dc:creator","label":"Author","values":["Westgate, Connar Stanley James"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-07-17"]},{"key":"dc:date.issued","label":"Date","values":["2019-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research (IMSR)"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/9002/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH301 Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/9002/7/Westgate2019PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Idiopathic intracranial hypertension (IIH) is a rare disease that primarily affects obese women of reproductive age, characterised by raised intracranial pressure (ICP) and papilloedema that drives chronic debilitating headache and visual loss. The aetiology of IIH is uncertain, however it is clear that weight loss is therapeutic and reduces ICP, headache, and visual morbidity. Novel data has highlighted that female IIH patients have an androgen excess phenotype. However the role of adipose tissue and androgens in the pathogenesis of IIH remains unclear. Utilising RNA-sequencing, NMR-based metabolomics and secretomic techniques, it has been identified that ex vivo subcutaneous adipose tissue from female IIH patients has features of glucocorticoid excess including increased lipolysis, ribosomal subunit depletion and a preference for lipid synthesis, driven by intra-adipose cortisol accumulation. Moreover, this phenotype is driving hyperleptinaemia in IIH patients. Additionally, a novel in vitro Na+/K+ ATPase activity assay was developed, which demonstrated that testosterone increases Na+/K+ ATPase activity, suggesting capacity to increase ICP. Together, these data highlight that adipose tissue in IIH has characteristics of glucocorticoid excess, contributing to a specific metabolic phenotype and that testosterone could be driving raised intracranial pressure, highlighting routes for the development of novel therapeutics and treatments for IIH."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Characterising the phenotype and impact of adipose in idiopathic intracranial hypertension"]}]}],"canonical_facts":{"dc:contributor.sponsor":["mrc","other"],"dc:creator":["Westgate, Connar Stanley James"],"dc:date":["2019-07-17"],"dc:date.issued":["2019-07"],"dc:description.abstract":["Idiopathic intracranial hypertension (IIH) is a rare disease that primarily affects obese women of reproductive age, characterised by raised intracranial pressure (ICP) and papilloedema that drives chronic debilitating headache and visual loss. The aetiology of IIH is uncertain, however it is clear that weight loss is therapeutic and reduces ICP, headache, and visual morbidity. Novel data has highlighted that female IIH patients have an androgen excess phenotype. However the role of adipose tissue and androgens in the pathogenesis of IIH remains unclear. Utilising RNA-sequencing, NMR-based metabolomics and secretomic techniques, it has been identified that ex vivo subcutaneous adipose tissue from female IIH patients has features of glucocorticoid excess including increased lipolysis, ribosomal subunit depletion and a preference for lipid synthesis, driven by intra-adipose cortisol accumulation. Moreover, this phenotype is driving hyperleptinaemia in IIH patients. Additionally, a novel in vitro Na+/K+ ATPase activity assay was developed, which demonstrated that testosterone increases Na+/K+ ATPase activity, suggesting capacity to increase ICP. Together, these data highlight that adipose tissue in IIH has characteristics of glucocorticoid excess, contributing to a specific metabolic phenotype and that testosterone could be driving raised intracranial pressure, highlighting routes for the development of novel therapeutics and treatments for IIH."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/9002/7/Westgate2019PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Metabolism and Systems Research (IMSR)"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/9002/"],"dc:subject":["QH301 Biology"],"dcterms:accessrights":["public"],"dc:title":["Characterising the phenotype and impact of adipose in idiopathic intracranial hypertension"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:30:27Z"}